ARTICLE | Company News
NascaCell, PSF Biotech, Xantos deal
April 18, 2005 7:00 AM UTC
The companies partnered to discover and develop angiogenesis inhibitors. The deal combines Xantos' target discovery and small molecule screening technology, PSF's protein production and crystallizatio...